Text Size
763 studies found for:    "Carcinoma, Hepatocellular"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Terminated Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma Non-resectable;   Hepatocellular Carcinoma Recurrent;   Carcinoma, Hepatocellular;   Liver Diseases;   Neoplasms by Histologic Type;   Digestive System Neoplasms;   Carcinoma;   Liver Neoplasms;   Neoplasms;   Neoplasms by Site;   Digestive System Diseases;   Adenocarcinoma;   Neoplasms, Glandular and Epithelial
Interventions: Drug: ABT-869;   Drug: Sorafenib
2 Terminated SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Hepatoma
Intervention: Device: SIR-Spheres microspheres
3 Active, not recruiting Combination SBRT (Stereotactic Body Radiotherapy) With TACE (Transarterial Chemoembolization) for Unresectable Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Hepatobiliary Neoplasm;   Liver Carcinoma
Interventions: Procedure: TACE;   Procedure: SBRT
4 Terminated Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma
Conditions: Cancer;   Liver Cancer;   Primary Liver Cancer;   Hepatocellular Carcinoma;   Hepatoma
Interventions: Drug: PI-88;   Drug: placebo
5 Recruiting A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
Conditions: Liver Tumors;   Hepatocellular Carcinoma;   Hepatoma;   Neoplasms
Intervention: Device: TheraSphere®
6 Unknown † Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Advanced Hepatocellular Carcinoma;   Metastatic Hepatocellular Carcinoma
Intervention: Drug: Sorafenib with Capecitabine and Oxaliplatin
7 Active, not recruiting Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer;   Hepatoma
Interventions: Device: Bead Block microspheres;   Other: Bead + Dox Arm
8 Recruiting the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma
Conditions: Stage I Hepatocellular Carcinoma;   Stage II Hepatocellular Carcinoma
Interventions: Drug: the ginsenoside Rg3;   Drug: Placebo
9 Recruiting Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients
Conditions: Cirrhosis With Hepatocellular Carcinoma;   Cirrhosis Without Hepatocellular Carcinoma
Interventions: Biological: Serum, plasma and DNA samples;   Procedure: Radiological exploration by CT scan or MRI
10 Recruiting Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma;   Liver Neoplasms;   Adenoma, Liver Cell;   Carcinoma, Hepatocellular
Interventions: Drug: TRC 105;   Drug: Sorafenib
11 Recruiting A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma
Conditions: Advanced Adult Hepatocellular Carcinoma;   Hepatocellular Carcinoma Metastatic
Intervention: Drug: AZD9150
12 Active, not recruiting Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatoma
Interventions: Drug: sorafenib;   Procedure: LC Bead-TACE
13 Recruiting Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatocellular Cancer;   Hepatoma;   Liver Cancer
Interventions: Drug: Sorafenib;   Radiation: Conventional fractionation (2 Gy per day) external beam radiation therapy
14 Recruiting Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib
Conditions: Hepatocellular Carcinoma;   Unresectable Hepatocellular Carcinoma;   Carcinoma, Hepatocellular;   Liver Neoplasm
Interventions: Drug: TACE with sorafenib;   Procedure: TACE alone
15 Completed A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Genetic: JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)
16 Recruiting Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: epirubicin;   Drug: Cisplatin
17 Unknown † Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Procedure: Transarterial Chemoembolization;   Radiation: Proton Beam Radiotherapy
18 Unknown † Proteomic Analysis of Human Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: Operation
19 Completed PI-88 in Hepatocellular Carcinoma After Hepatectomy
Condition: Carcinoma, Hepatocellular
Intervention: Drug: PI-88
20 Unknown † Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma
Conditions: Hepatitis B;   Carcinoma, Hepatocellular;   Polymorphism, Genetic
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years